![]() ![]() History of migraine with focal neurological symptoms.ĩ. A high risk of venous or arterial thrombosis (see section 4.4)Ĩ. transient ischaemic attack, angina pectoris).ħ. Presence or a history of prodromi of a thrombosis (e.g. Active or recent arterial thromboembolic disease (e.g. Previous idiopathic or current venous thromboembolism (deep vein thrombosis, pulmonary embolism).ĥ. Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.Ĥ. Should any of the conditions appear during the use of Primolut N, the use of the product should be stopped immediately.ġ. ![]() Primolut N should not be used in the presence of any of the conditions listed below. ![]() The tablets are to be swallowed whole with some liquid. A further course of therapy may be employed if symptoms return. Treatment should be maintained for three to four cycles followed by treatment-free cycles. 1 tablet three times daily for 20 days, starting on the fifth day of the cycle (the first day of menstruation counting as day 1). Menorrhagia (hypermenorrhoea): 1 tablet 2-3 times a day from the 19 th to the 26 th day of the cycle (counting the first day of menstruation as day 1).ĭysmenorrhoea: Functional or primary dysmenorrhoea is almost invariably relieved by the suppression of ovulation. With uninterrupted daily intake, ovulation and menstruation do not usually occur. Treatment is to be continued for at least 4 to 6 months. If bleeding ceases, dose reduction to the initial dose should be considered. In the event of spotting, the dose can be increased to 2 tablets twice daily. This method should be restricted to users who are not at risk of pregnancy during the treatment cycle.Įndometriosis (pseudo-pregnancy therapy): Treatment should begin between the first and 5th day of the cycle with 1 of tablet Primolut N twice daily. A normal period should occur 2-3 days after the patient has stopped taking tablets. The dosage is 1 tablet of Primolut N three times daily, starting 3 days before the expected onset of menstruation and continuing for not longer than 10 to 14 days. operations, travel, sports) the postponement of menstruation is possible. Postponement of menstruation: In cases of too frequent menstrual bleeding, and in special circumstances (e.g. When treatment is stopped, the patient may remain symptom-free for a number of months. Treatment should be repeated for several cycles. Premenstrual syndrome (including premenstrual mastalgia): Premenstrual symptoms such as headache, migraine, breast discomfort, water retention, tachycardia, and psychological disturbances may be relieved by the administration of 1-3 tablets daily from the 19 th to the 26 th day of the cycle. This also applies to cases where after an initial suspension of bleeding, fairly heavy bleeding reoccurs during tablet intake. polyps, carcinoma of the cervix uteri or endometrium, myoma, residua of abortion, extra-uterine pregnancy, or coagulation disorders) must be considered so that other measures are then mostly required. If vaginal bleeding does not stop, despite correct tablet intake, an organic cause or an extra-genital factor (e.g. Treatment should not be interrupted or suspended in these cases. Occasionally, slight bleeding may occur after the initial suspension of bleeding. To ensure treatment success, Primolut N must be taken for the full 10 days. One tablet twice daily from the 19 th to the 26 th day of the two subsequent cycles should be given to prevent recurrence of the condition. A withdrawal bleeding resembling normal menstruation occurs within 2-4 days after discontinuing treatment. Bleeding is arrested usually within 1-3 days. Metropathia haemorrhagica (dysfunctional uterine bleeding): 1 tablet 3 times daily for 10 days. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |